ESMO 2026 Presidential Symposia: From Trial Results to Clinical Implications
Phase II Trial Shows Promising Pathologic Responses With Neoadjuvant Nivolumab and Chemotherapy in Salivary Gland Cancer
OncoDaily and Natera Present “Seismic Shift: Innovations in MRD Testing and Pathology”
High CA-125 Levels: Causes, Normal Range and Cancer Risk
Sara Tolaney: Breast Cancer Insights From ESMO 2026
NEOASIS at ESMO 2026: Neoadjuvant Botensilimab Plus Balstilimab in dMMR Colorectal Cancer
ESMO 2026: What’s New in Melanoma Immunotherapy?
A National Multidisciplinary BC Course Has Trained 180 Clinicians Across Mongolia - UICC
OncoDaily RT is the dedicated radiation oncology platform of OncoDaily, focused on the rapidly evolving field of radiotherapy and cancer treatment. It covers clinical research, treatment advances, technology, education, and global collaboration, including precision radiotherapy, stereotactic radiotherapy, brachytherapy, adaptive radiotherapy, proton therapy, artificial intelligence, treatment toxicity, survivorship, patient-centered care, and integration with systemic treatments. Through OncoDaily RT, radiation oncologists, medical physicists, researchers, trainees, industry partners, and multidisciplinary cancer care professionals can follow the latest research, emerging technologies, treatment innovations, congress updates, expert perspectives, interviews, articles, social media coverage, and expert-led discussions, while sharing knowledge and advancing radiation oncology worldwide.
